Austar Lifesciences Limited (6118.HK) Stock Price, News, Quote & History - Yahoo Finance
HKSE - Delayed Quote HKD

Austar Lifesciences Limited (6118.HK)

0.760 0.000 (0.00%)
At close: 4:08 PM GMT+8
Loading Chart for 6118.HK
DELL
  • Previous Close 0.760
  • Open 0.750
  • Bid 0.760 x --
  • Ask 0.770 x --
  • Day's Range 0.740 - 0.810
  • 52 Week Range 0.730 - 3.180
  • Volume 198,240
  • Avg. Volume 488,024
  • Market Cap (intraday) 389.562M
  • Beta (5Y Monthly) 1.07
  • PE Ratio (TTM) --
  • EPS (TTM) -0.060
  • Earnings Date Mar 27, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 19, 2015
  • 1y Target Est --

Austar Lifesciences Limited, an investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through six segments: Liquid and Bioprocess System; Clean Room and Automation Control and Monitoring System; Powder and Solid System; GMP Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment. The company offers liquid and bioprocess systems, including pharmaceutical water, and liquid preparation and bioprocess systems; clean room enclosure, automation control and monitoring systems; and freeze-dryer, sterile filling, and visual inspection equipment, as well as clean utility, powder, and solid equipment and systems. It also provides pharmaceutical process contamination control products; packaging and aseptic containment products; biosafety and lab animal equipment and consumables; laboratory one-stop solutions; and single-use bioprocess equipment and consumables. In addition, the company offers pharmaceutical engineering design, consulting, process technology, facility operations and maintenance, laboratory and digitalization construction, quality risk control, and research and development services. Further, it is involved in the agency and distribution of pharmaceutical equipment, as well as provides contract execution, assembly and pre-assembly, and GMP compliance services. The company was founded in 1991 and is headquartered in Shanghai, China.

www.austar.com.hk

1,610

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 6118.HK

Trailing total returns as of 5/2/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

6118.HK
51.28%
HANG SENG INDEX
6.80%

1-Year Return

6118.HK
60.00%
HANG SENG INDEX
8.48%

3-Year Return

6118.HK
89.70%
HANG SENG INDEX
36.62%

5-Year Return

6118.HK
87.12%
HANG SENG INDEX
38.69%

Compare To: 6118.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6118.HK

Valuation Measures

Annual
As of 4/30/2024
  • Market Cap

    389.56M

  • Enterprise Value

    737.93M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.20

  • Price/Book (mrq)

    0.47

  • Enterprise Value/Revenue

    0.42

  • Enterprise Value/EBITDA

    29.34

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -6.43%

  • Return on Assets (ttm)

    -1.00%

  • Return on Equity (ttm)

    -4.19%

  • Revenue (ttm)

    1.76B

  • Net Income Avi to Common (ttm)

    -32.61M

  • Diluted EPS (ttm)

    -0.060

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    173.76M

  • Total Debt/Equity (mrq)

    63.99%

  • Levered Free Cash Flow (ttm)

    --

Company Insights: 6118.HK

People Also Watch